Trial Profile
A PHASE I, SINGLE-CENTER, OPEN-LABEL, CROSSOVER STUDY OF THE EFFECT OF AVANAFIL ON THE PHARMACOKINETICS OF OMEPRAZOLE, DESIPRAMINE AND ROSIGLITAZONE IN HEALTHY MALE SUBJECTS
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Dec 2021
Price :
$35
*
At a glance
- Drugs Avanafil (Primary) ; Desipramine; Omeprazole; Rosiglitazone
- Indications Depression; Duodenal ulcer; Dyspepsia; Erectile dysfunction; Gastric ulcer; Gastritis; Gastro-oesophageal reflux; Helicobacter infections; Peptic ulcer; Type 2 diabetes mellitus; Zollinger-Ellison syndrome
- Focus Pharmacokinetics
- 15 Aug 2011 New trial record